Equillium Inc. buy BiotechBee
Start price
03.03.24
/
50%
€2.19
Target price
31.05.26
€6.00
Performance (%)
-68.04%
End price
14.12.24
€0.70
Summary
This prediction ended on 14.12.24 with a price of €0.70. The BUY prediction by BiotechBee for Equillium Inc. performed very badly with a performance of -68.04%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Equillium Inc. | - | - | - |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Equillium Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Equillium Inc. diskutieren
In the thread Trading Equillium Inc.
Stopped prediction by BiotechBee for Equillium Inc.
Equillium Inc.
Start price
Target price
Perf. (%)
€2.69
17.02.24
17.02.24
€4.00
30.09.25
30.09.25
-18.44%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year
